APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Voltaren

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Voltaren Industry Growth and Trends Forecast to 2032

Report ID 174047190120 December 202599 pages

Choose your research edition.

Industry ResearchVoltaren Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Voltaren Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Voltaren Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Voltaren Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Voltaren Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Voltaren market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Voltaren is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Voltaren is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Voltaren is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Voltaren include Endo Pharmaceuticals, Enovachem Pharmaceuticals, Hainan Quanxing Pharmaceutical, Iroko Pharmaceuticals, Jewim Pharmaceutical, Supor South Ocean, GSK and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Voltaren market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Voltaren market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Voltaren market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Voltaren.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Voltaren market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Voltaren Market by Company

Endo Pharmaceuticals

Enovachem Pharmaceuticals

Hainan Quanxing Pharmaceutical

Iroko Pharmaceuticals

Jewim Pharmaceutical

Supor South Ocean

GSK

Novartis

Voltaren Segment by Type

Injection

Tablet

Spray

Gel

Capsule

Voltaren Segment by Application

Elderly

Adults

Voltaren Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Voltaren market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Voltaren and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Voltaren.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Voltaren manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Voltaren in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Tablet Table 3. Major Company of Spray Table 4. Major Company of Gel Table 5. Major Company of Capsule Table 6. Global Voltaren Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Voltaren Sales by Type (2021-2026) & (K Units) Table 8. Global Voltaren Sales Market Share in Volume by Type (2021-2026) Table 9. Global Voltaren Sales by Type (2021-2026) & (US$ Million) Table 10. Global Voltaren Sales Market Share in Value by Type (2021-2026) Table 11. Global Voltaren Price by Type (2021-2026) & (US$/Unit) Table 12. Global Voltaren Sales by Type (2027-2032) & (K Units) Table 13. Global Voltaren Sales Market Share in Volume by Type (2027-2032) Table 14. Global Voltaren Sales by Type (2027-2032) & (US$ Million) Table 15. Global Voltaren Sales Market Share in Value by Type (2027-2032) Table 16. Global Voltaren Price by Type (2027-2032) & (US$/Unit) Table 17. North America Voltaren Sales by Type (2021-2026) & (K Units) Table 18. North America Voltaren Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Voltaren Sales by Type (2021-2026) & (K Units) Table 20. Europe Voltaren Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Voltaren Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Voltaren Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Voltaren Sales by Type (2021-2026) & (K Units) Table 24. Latin America Voltaren Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Voltaren Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Voltaren Sales by Type (2021-2026) & (US$ Million) Table 27. Voltaren Industry Trends Table 28. Voltaren Industry Drivers Table 29. Voltaren Industry Opportunities and Challenges Table 30. Voltaren Industry Restraints Table 31. Global Voltaren Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Voltaren Revenue Market Share by Company (2021-2026) Table 33. Global Voltaren Sales by Company (2021-2026) & (K Units) Table 34. Global Voltaren Sales Share by Company (2021-2026) Table 35. Global Voltaren Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Voltaren Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Voltaren Major Company Production Sites and Headquarters Table 38. Global Voltaren Company, Product Type & Application Table 39. Global Voltaren Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Voltaren by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Voltaren Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Voltaren Sales by Region (2021-2026) & (K Units) Table 44. Global Voltaren Sales Market Share in Volume by Region (2021-2026) Table 45. Global Voltaren Sales by Region (2021-2026) & (US$ Million) Table 46. Global Voltaren Sales Market Share in Value by Region (2021-2026) Table 47. Global Voltaren Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Voltaren Sales by Region (2027-2032) & (K Units) Table 49. Global Voltaren Sales Market Share in Volume by Region (2027-2032) Table 50. Global Voltaren Sales by Region (2027-2032) & (US$ Million) Table 51. Global Voltaren Sales Market Share in Value by Region (2027-2032) Table 52. Global Voltaren Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Voltaren Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Voltaren Sales by Application (2021-2026) & (K Units) Table 55. Global Voltaren Sales Market Share in Volume by Application (2021-2026) Table 56. Global Voltaren Sales by Application (2021-2026) & (US$ Million) Table 57. Global Voltaren Sales Market Share in Value by Application (2021-2026) Table 58. Global Voltaren Price by Application (2021-2026) & (US$/Unit) Table 59. Global Voltaren Sales by Application (2027-2032) & (K Units) Table 60. Global Voltaren Sales Market Share in Volume by Application (2027-2032) Table 61. Global Voltaren Sales by Application (2027-2032) & (US$ Million) Table 62. Global Voltaren Sales Market Share in Value by Application (2027-2032) Table 63. Global Voltaren Price by Application (2027-2032) & (US$/Unit) Table 64. North America Voltaren Sales by Application (2021-2026) & (K Units) Table 65. North America Voltaren Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Voltaren Sales by Application (2021-2026) & (K Units) Table 67. Europe Voltaren Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Voltaren Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Voltaren Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Voltaren Sales by Application (2021-2026) & (K Units) Table 71. Latin America Voltaren Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Voltaren Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Voltaren Sales by Application (2021-2026) & (US$ Million) Table 74. Endo Pharmaceuticals Company Information Table 75. Endo Pharmaceuticals Business Overview Table 76. Endo Pharmaceuticals Voltaren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Endo Pharmaceuticals Voltaren Product Portfolio Table 78. Endo Pharmaceuticals Recent Development Table 79. Enovachem Pharmaceuticals Company Information Table 80. Enovachem Pharmaceuticals Business Overview Table 81. Enovachem Pharmaceuticals Voltaren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Enovachem Pharmaceuticals Voltaren Product Portfolio Table 83. Enovachem Pharmaceuticals Recent Development Table 84. Hainan Quanxing Pharmaceutical Company Information Table 85. Hainan Quanxing Pharmaceutical Business Overview Table 86. Hainan Quanxing Pharmaceutical Voltaren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Hainan Quanxing Pharmaceutical Voltaren Product Portfolio Table 88. Hainan Quanxing Pharmaceutical Recent Development Table 89. Iroko Pharmaceuticals Company Information Table 90. Iroko Pharmaceuticals Business Overview Table 91. Iroko Pharmaceuticals Voltaren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Iroko Pharmaceuticals Voltaren Product Portfolio Table 93. Iroko Pharmaceuticals Recent Development Table 94. Jewim Pharmaceutical Company Information Table 95. Jewim Pharmaceutical Business Overview Table 96. Jewim Pharmaceutical Voltaren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Jewim Pharmaceutical Voltaren Product Portfolio Table 98. Jewim Pharmaceutical Recent Development Table 99. Supor South Ocean Company Information Table 100. Supor South Ocean Business Overview Table 101. Supor South Ocean Voltaren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Supor South Ocean Voltaren Product Portfolio Table 103. Supor South Ocean Recent Development Table 104. GSK Company Information Table 105. GSK Business Overview Table 106. GSK Voltaren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. GSK Voltaren Product Portfolio Table 108. GSK Recent Development Table 109. Novartis Company Information Table 110. Novartis Business Overview Table 111. Novartis Voltaren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Novartis Voltaren Product Portfolio Table 113. Novartis Recent Development Table 114. North America Voltaren Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 115. North America Voltaren Sales by Country (2021-2026) & (K Units) Table 116. North America Voltaren Sales Market Share by Country (2021-2026) Table 117. North America Voltaren Sales Forecast by Country (2027-2032) & (K Units) Table 118. North America Voltaren Sales Market Share Forecast by Country (2027-2032) Table 119. North America Voltaren Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. North America Voltaren Market Size by Country (2021-2026) & (US$ Million) Table 121. North America Voltaren Market Share by Country (2021-2026) Table 122. North America Voltaren Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. North America Voltaren Market Share Forecast by Country (2027-2032) Table 124. Europe Voltaren Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. Europe Voltaren Sales by Country (2021-2026) & (K Units) Table 126. Europe Voltaren Sales Market Share by Country (2021-2026) Table 127. Europe Voltaren Sales Forecast by Country (2027-2032) & (K Units) Table 128. Europe Voltaren Sales Market Share Forecast by Country (2027-2032) Table 129. Europe Voltaren Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Europe Voltaren Market Size by Country (2021-2026) & (US$ Million) Table 131. Europe Voltaren Market Share by Country (2021-2026) Table 132. Europe Voltaren Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Europe Voltaren Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Voltaren Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Voltaren Sales by Country (2021-2026) & (K Units) Table 136. Asia-Pacific Voltaren Sales Market Share by Country (2021-2026) Table 137. Asia-Pacific Voltaren Sales Forecast by Country (2027-2032) & (K Units) Table 138. Asia-Pacific Voltaren Sales Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Voltaren Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Voltaren Market Size by Country (2021-2026) & (US$ Million) Table 141. Asia-Pacific Voltaren Market Share by Country (2021-2026) Table 142. Asia-Pacific Voltaren Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Asia-Pacific Voltaren Market Share Forecast by Country (2027-2032) Table 144. Latin America Voltaren Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. Latin America Voltaren Sales by Country (2021-2026) & (K Units) Table 146. Latin America Voltaren Sales Market Share by Country (2021-2026) Table 147. Latin America Voltaren Sales Forecast by Country (2027-2032) & (K Units) Table 148. Latin America Voltaren Sales Market Share Forecast by Country (2027-2032) Table 149. Latin America Voltaren Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Latin America Voltaren Market Size by Country (2021-2026) & (US$ Million) Table 151. Latin America Voltaren Market Share by Country (2021-2026) Table 152. Latin America Voltaren Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Latin America Voltaren Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Voltaren Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Voltaren Sales by Country (2021-2026) & (K Units) Table 156. Middle East and Africa Voltaren Sales Market Share by Country (2021-2026) Table 157. Middle East and Africa Voltaren Sales Forecast by Country (2027-2032) & (K Units) Table 158. Middle East and Africa Voltaren Sales Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Voltaren Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Voltaren Market Size by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Voltaren Market Share by Country (2021-2026) Table 162. Middle East and Africa Voltaren Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Middle East and Africa Voltaren Market Share Forecast by Country (2027-2032) Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Voltaren Distributors List Table 167. Voltaren Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Voltaren Image Figure 2. Global Voltaren Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Voltaren Market Size (2021-2032) & (US$ Million) Figure 4. Global Voltaren Sales (2021-2032) & (K Units) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tablet Image Figure 8. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. Spray Image Figure 10. Global Spray Sales YoY Growth (2021-2032) & (K Units) Figure 11. Gel Image Figure 12. Global Gel Sales YoY Growth (2021-2032) & (K Units) Figure 13. Capsule Image Figure 14. Global Capsule Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Voltaren Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Voltaren Market Share by Type 2025 VS 2032 Figure 17. North America Voltaren Sales Market Share in Volume by Type in 2025 Figure 18. North America Voltaren Sales Market Share in Value by Type in 2025 Figure 19. Europe Voltaren Sales Market Share in Volume by Type in 2025 Figure 20. Europe Voltaren Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Voltaren Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Voltaren Sales Market Share in Value by Type in 2025 Figure 23. Latin America Voltaren Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Voltaren Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Voltaren Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Voltaren Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Voltaren Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Elderly Image Figure 30. Global Elderly Sales YoY Growth (2021-2032) & (K Units) Figure 31. Adults Image Figure 32. Global Adults Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Voltaren Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Voltaren Market Share by Application 2025 VS 2032 Figure 35. North America Voltaren Sales Market Share in Volume by Application in 2025 Figure 36. North America Voltaren Sales Market Share in Value by Application in 2025 Figure 37. Europe Voltaren Sales Market Share in Volume by Application in 2025 Figure 38. Europe Voltaren Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Voltaren Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Voltaren Sales Market Share in Value by Application in 2025 Figure 41. Latin America Voltaren Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Voltaren Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Voltaren Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Voltaren Sales Market Share in Value by Application in 2025 Figure 45. North America Voltaren Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Voltaren Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Voltaren Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Voltaren Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Voltaren Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Voltaren Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Voltaren Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Voltaren Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Voltaren Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Voltaren Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Voltaren Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Voltaren Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Voltaren Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Voltaren Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Voltaren Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Voltaren Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Voltaren Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Voltaren Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Voltaren Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Voltaren Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Voltaren Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Voltaren Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablet
  • Spray
  • Gel
  • Capsule
Applications
  • Elderly
  • Adults
Companies covered
  • Endo Pharmaceuticals
  • Enovachem Pharmaceuticals
  • Hainan Quanxing Pharmaceutical
  • Iroko Pharmaceuticals
  • Jewim Pharmaceutical
  • Supor South Ocean
  • GSK
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Voltaren Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Voltaren Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Voltaren Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Tablet
  8. 1.3.3 Spray
  9. 1.3.4 Gel
  10. 1.3.5 Capsule
  11. 1.4 Global Voltaren Market Size by Type
  12. 1.4.1 Global Voltaren Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Voltaren Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Voltaren Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Voltaren Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Voltaren Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Voltaren Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Voltaren Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Voltaren Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Voltaren Industry Trends
  2. 2.2 Voltaren Industry Drivers
  3. 2.3 Voltaren Industry Opportunities and Challenges
  4. 2.4 Voltaren Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Voltaren Revenue (2021-2026)
  2. 3.2 Global Top Players by Voltaren Sales (2021-2026)
  3. 3.3 Global Top Players by Voltaren Price (2021-2026)
  4. 3.4 Global Voltaren Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Voltaren Major Company Production Sites & Headquarters
  6. 3.6 Global Voltaren Company, Product Type & Application
  7. 3.7 Global Voltaren Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Voltaren Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Voltaren Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Voltaren Tier 1, Tier 2, and Tier 3
4 Voltaren Regional Status and Outlook
  1. 4.1 Global Voltaren Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Voltaren Historic Market Size by Region
  3. 4.2.1 Global Voltaren Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Voltaren Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Voltaren Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Voltaren Forecasted Market Size by Region
  7. 4.3.1 Global Voltaren Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Voltaren Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Voltaren Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Voltaren by Application
  1. 5.1 Voltaren Market by Application
  2. 5.1.1 Elderly
  3. 5.1.2 Adults
  4. 5.2 Global Voltaren Market Size by Application
  5. 5.2.1 Global Voltaren Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Voltaren Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Voltaren Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Voltaren Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Voltaren Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Voltaren Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Voltaren Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Voltaren Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Endo Pharmaceuticals
  2. 6.1.1 Endo Pharmaceuticals Company Information
  3. 6.1.2 Endo Pharmaceuticals Business Overview
  4. 6.1.3 Endo Pharmaceuticals Voltaren Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Endo Pharmaceuticals Voltaren Product Portfolio
  6. 6.1.5 Endo Pharmaceuticals Recent Developments
  7. 6.2 Enovachem Pharmaceuticals
  8. 6.2.1 Enovachem Pharmaceuticals Company Information
  9. 6.2.2 Enovachem Pharmaceuticals Business Overview
  10. 6.2.3 Enovachem Pharmaceuticals Voltaren Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Enovachem Pharmaceuticals Voltaren Product Portfolio
  12. 6.2.5 Enovachem Pharmaceuticals Recent Developments
  13. 6.3 Hainan Quanxing Pharmaceutical
  14. 6.3.1 Hainan Quanxing Pharmaceutical Company Information
  15. 6.3.2 Hainan Quanxing Pharmaceutical Business Overview
  16. 6.3.3 Hainan Quanxing Pharmaceutical Voltaren Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hainan Quanxing Pharmaceutical Voltaren Product Portfolio
  18. 6.3.5 Hainan Quanxing Pharmaceutical Recent Developments
  19. 6.4 Iroko Pharmaceuticals
  20. 6.4.1 Iroko Pharmaceuticals Company Information
  21. 6.4.2 Iroko Pharmaceuticals Business Overview
  22. 6.4.3 Iroko Pharmaceuticals Voltaren Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Iroko Pharmaceuticals Voltaren Product Portfolio
  24. 6.4.5 Iroko Pharmaceuticals Recent Developments
  25. 6.5 Jewim Pharmaceutical
  26. 6.5.1 Jewim Pharmaceutical Company Information
  27. 6.5.2 Jewim Pharmaceutical Business Overview
  28. 6.5.3 Jewim Pharmaceutical Voltaren Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Jewim Pharmaceutical Voltaren Product Portfolio
  30. 6.5.5 Jewim Pharmaceutical Recent Developments
  31. 6.6 Supor South Ocean
  32. 6.6.1 Supor South Ocean Company Information
  33. 6.6.2 Supor South Ocean Business Overview
  34. 6.6.3 Supor South Ocean Voltaren Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Supor South Ocean Voltaren Product Portfolio
  36. 6.6.5 Supor South Ocean Recent Developments
  37. 6.7 GSK
  38. 6.7.1 GSK Company Information
  39. 6.7.2 GSK Business Overview
  40. 6.7.3 GSK Voltaren Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GSK Voltaren Product Portfolio
  42. 6.7.5 GSK Recent Developments
  43. 6.8 Novartis
  44. 6.8.1 Novartis Company Information
  45. 6.8.2 Novartis Business Overview
  46. 6.8.3 Novartis Voltaren Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Novartis Voltaren Product Portfolio
  48. 6.8.5 Novartis Recent Developments
7 North America by Country
  1. 7.1 North America Voltaren Sales by Country
  2. 7.1.1 North America Voltaren Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Voltaren Sales by Country (2021-2026)
  4. 7.1.3 North America Voltaren Sales Forecast by Country (2027-2032)
  5. 7.2 North America Voltaren Market Size by Country
  6. 7.2.1 North America Voltaren Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Voltaren Market Size by Country (2021-2026)
  8. 7.2.3 North America Voltaren Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Voltaren Sales by Country
  2. 8.1.1 Europe Voltaren Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Voltaren Sales by Country (2021-2026)
  4. 8.1.3 Europe Voltaren Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Voltaren Market Size by Country
  6. 8.2.1 Europe Voltaren Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Voltaren Market Size by Country (2021-2026)
  8. 8.2.3 Europe Voltaren Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Voltaren Sales by Country
  2. 9.1.1 Asia-Pacific Voltaren Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Voltaren Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Voltaren Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Voltaren Market Size by Country
  6. 9.2.1 Asia-Pacific Voltaren Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Voltaren Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Voltaren Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Voltaren Sales by Country
  2. 10.1.1 South America Voltaren Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Voltaren Sales by Country (2021-2026)
  4. 10.1.3 South America Voltaren Sales Forecast by Country (2027-2032)
  5. 10.2 South America Voltaren Market Size by Country
  6. 10.2.1 South America Voltaren Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Voltaren Market Size by Country (2021-2026)
  8. 10.2.3 South America Voltaren Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Voltaren Sales by Country
  2. 11.1.1 Middle East and Africa Voltaren Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Voltaren Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Voltaren Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Voltaren Market Size by Country
  6. 11.2.1 Middle East and Africa Voltaren Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Voltaren Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Voltaren Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Voltaren Value Chain Analysis
  2. 12.1.1 Voltaren Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Voltaren Production Mode & Process
  7. 12.2 Voltaren Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Voltaren Distributors
  10. 12.2.3 Voltaren Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst